BioTech Medics Announces SHBAN Antiviral Solution Undergoing H1N1 (Swine) Influenza Efficacy Testing
July 14 2009 - 10:02AM
Marketwired
BioTech Medics, Inc. (PINKSHEETS: BMCS) announces that it has
contracted to start conducting independent clinical testing of its
patented SHBAN(TM) Antiviral Hand Sanitizer Solution to prove it
kills the H1N1 (Swine) Influenza A virus in compliance with FDA and
EPA standards.
In 2007 BioTech conducted an independent study to determine the
efficacy of virucidal SHBAN against Avian H5N1 Influenza NIBRG-14
Virus (also known as the Avian Bird Flu). BioTech reported that the
SHBAN Solution had clinically proven its anti-viral properties and
had topically killed the Avian Influenza virus. Significantly,
SHBAN was proven non-toxic with "no cytotoxicity observed on the
MDCK cell line after treatment."
SHBAN is a bio-degradable product superior to most anti-viral
and anti-bacterial disinfectants because 1) SHBAN is longer
lasting, SHBAN does not evaporate within 15 seconds after
application and cease working (like alcohol gels); 2) SHBAN is
non-toxic when used as directed on humans and animals; 3) SHBAN is
non-staining, non-bleaching; 4) SHBAN is non-flammable and 5) SHBAN
has no harmful or toxic odors. Most hand sanitizer products cannot
make all of these claims.
BioTech currently sells a 3 oz SHBAN(TM) Go Anywhere Hand
Atomizer Spray Bottle that complies with TSA carry-on travel
regulations. SHBAN sales are up significantly in 2009. BioTech is
releasing this Fall 1 oz and 16 oz bottles together with SHBAN Hand
Wipe Towelettes.
The World Health Organization (WHO) has declared the H1N1
Influenza a worldwide pandemic 6, so it is essential that people
buying hand sanitizers know that SHBAN can prove that SHBAN kills
the H1N1 Influenza Virus on the hands. SHBAN is protected under US
Letters of Patent #5,514,808, #5,574,050, #5,679,711 and #5,585,391
and pending international patents. SHBAN is a trademark of BioTech
Medics, Inc. BioTech is seeking and negotiating USA and foreign
distributorships at this time.
SHBAN(TM) in previous in vitro and in vivo testing has been
evaluated for its antimicrobial properties against Staph. Aureus,
Staph. Epidermidis, EC. Faecalis, E. Coli and Ps. Aeruginosa.
Safe Harbor: Forward-Looking Statements
This release contains forward-looking statements within the
meaning of The Private Securities Litigation Reform Act of 1995
(the "Act"). The statements above have not been evaluated by the
FDA. SHBAN is not intended to diagnose, treat or cure any
disease.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact: Tom Wood Sr. V.P. Sales Phone 972-849-3782
BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Jun 2024 to Jul 2024
BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Jul 2023 to Jul 2024